Please join us in our efforts to request the FDA start BCG Expanded Access Protocol for T1D NOW and reverse Type 1 Diabetes!

President Trump has recently advocated for faster access to drugs that might fight against the COVID-19 crisis. As American Citizens, We stand as one united front in urging the President to have this same type of game changing presidential action to help Americans with Type 1 Diabetes.

Type 1 Diabetes is caused by insufficient insulin hormone production by the pancreas. Children and adults alike living with the disease must measure their blood sugar multiple times a day and inject their bodies with insulin to prevent blood sugar from fluctuating too high. Presently, the very drug that will keep a type 1 diabetic alive (insulin) is also the very drug that will kill them if injected in too high or too low of doses.

The public health burden of type 1 diabetes is enormous. Over 1.25 million Americans suffer daily with this disease. Each year another 40,000 are diagnosed and its onset and progression does not discriminate age, race, or gender. Massachusetts General Hospital (MGH) has conducted a successful Phase I trial that demonstrated the safety and efficacy of bacille Calmette-Guerin (BCG) in Type 1 Diabetes. A Phase II trial is underway, & MGH hereby requests to make BCG available NOW in order to save lives and reverse T1D. Massachusetts General Hospital has submitted a formal request to the FDA 9 months ago to begin an Expanded Access protocol for type 1 diabetics to receive the BCG vaccine. Expanded Access protocols are usually approved in 30 days. President Trump, will you Please Hear Our Voices & give directives to the FDA to start the BCG Expanded Access Protocol for type 1 diabetes.

Americans live with T1D
Increase in cases since 2017
Leading Cause of Death in the U.S.

Image shows approximately one month of insulin injections for a type 1 diabetic child


Think Big. Act Bigger. Never Give Up Hope.

Type 1 diabetes (T1D) is currently an incurable, autoimmune disease. It is not a lifestyle disease. T1D accounts for roughly 10% of the more than 420 million global cases of diabetes, and people with Type 1 are insulin-dependent for life.